COM:RADIUSPHARM
Radius Health
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
radiuspharm.com/ipo date
Jun 06, 2014
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment ...Show More